Antiviral antibodies produced by survivors of Ebola infection continue to evolve and improve after recovery, according to a detailed study of the immune responses of four people who received care at Emory University Hospital in 2014. In particular, high levels of neutralizing antibodies- thought to be key to protecting someone against deadly infection—didn’t appear in […]